Clinical Trials Browser

Multiple Myeloma × Ascorbic Acid × 1 year × Clear all

NCT03602235 2025-10-21

High Dose Ascorbic Acid for Plasma Cell Disorders

Phase 1 Completed

Multiple Myeloma

NCT01125449 2025-05-18

Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease

Phase 2 Withdrawn

Plasma cellSarcoma

Adenocarcinoma, Carcinoma, Multiple Myeloma, Sarcoma, Desmoplastic Small Round Cell Tumor